Complete MEI Pharma Inc. stock information by Barron's. View real-time MEIP stock price and news, along with industry-best analysis. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. Sector Health Care Industry Biotechnology Employees 76 Founded 2000 Address 11455 El Camino Real San. Mei Pharma Inc (MEIP) Latest News & Price | InvestorPlace MEI Pharma (NASDAQ:MEIP), Analyst Ratings, Price Targets, Predictions MEI Pharma, Inc. (MEIP) Stock Price Today, Quote & News MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at ... MEIP | MEI Pharma Inc. Analyst Estimates | MarketWatch MEIP | MEI Pharma Inc. Stock Overview (U.S.: Nasdaq) | Barron's Complete MEI Pharma Inc. stock information by Barron's. View real-time MEIP stock price and news, along with industry-best analysis. Their forecasts range from $1.00 to $20.00. web search. Based on 9 Wall Street analysts offering 12 month price targets for MEI Pharma in the last 3 months. SAN DIEGO & TOKYO, June 04, 2022--MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced data from the ongoing Phase 2 TIDAL study evaluating the . Past 12 Months 12 Months Forecast -$1 $3.25 $7.5 $11.75 $16 Aug 2021 Nov MEIP Stock | News | MEI PHARMA Stock Price Today | Analyst Opinions ... Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. . In the previous week, MEI Pharma had 1 more articles in the media than AC Immune. MarketBeat recorded 5 mentions for MEI Pharma and 4 mentions for AC Immune. MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at ... MEI Pharma (NASDAQ: MEIP) was reported by BTIG on March 25, 2022.The analyst firm set a price target for $4.00 expecting MEIP to rise to within 12 months (a possible . On average, Wall Street analysts predict that MEI PHARMA 's share price could reach $2.83 by Mar 25, 2023. MEIP - Mei Pharma Stock Price - Barchart.com MEI Pharma, Inc. (MEIP) Stock Price, Quote & News - Stock Analysis A development stage company, engaged in the clinical development of the anti-cancer drug phenoxodiol. The latest price target for . MEI Pharma, Inc. (MEIP) Analyst Ratings, Estimates & Forecasts - Yahoo! MEIP : 0.5566 (-6.03%) MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments Business Wire - Mon Feb 7, 7:00AM CST. MEIP - Research and Analysis for MEI PHARMA, INC. - MSN Investors in MEI Pharma, Inc. (MEIP Quick Quote MEIP - Free Report) need to pay close attention to the stock based on moves in the options market lately.That is because the Jun 19, 2020 $5.00 Call . View MEI Pharma, Inc MEIP investment & stock information. MEIP - Mei Pharma Stock Price - Barchart.com MEIP - MEI Pharma Inc Stock quote - CNNMoney.com The average twelve-month price prediction for MEI Pharma is $5.13 with a high price target of $20.00 and a low price target of $1.00. MEI Pharma's portfolio of drug candidates contains multiple clinical-stage assets, including zandelisib, currently in ongoing clinical trials which may support marketing approvals with the U.S. Food . MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at ... The average price target represents a 787.78% change from the last price of $0.56. is Investigating MEI Pharma, Inc. on Behalf of MEI Stockholders and Encourages Investors to Contact the Firm BU 05/17 MEIP | MEI Pharma Inc. Analyst Estimates & Rating - WSJ MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. What was the 52-week high for MEI Pharma stock? Stock Picks. The current price MEI Pharma ( MEIP) is trading at is . MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. msn back to msn home money. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the expansion of its management team with the addition of two . Their forecasts range from $1.00 to $20.00. Today's 52-Week Highs; Today's 52-Week Lows; Volume . According to the issued ratings of 7 analysts in the last year, the consensus rating for MEI Pharma stock is Buy based on the current 3 hold ratings and 4 buy ratings for MEIP. Revenues are expected to be $7.62 million, down 16.9%. Find real-time MEIP - MEI Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. MEIP Stock Forecast, Price & News (MEI Pharma) - MarketBeat Stock Price Prediction: Update at 5:00pm EST: If tomorrow: Open lower Open higher High: 0.56 - 0.57 0.57 - 0.57 Low: . About MEI Pharma. web search. MEIP will report Q3 2022 earnings on 09/01/2022. The average price target is $5.00 with a high forecast of $15.00 and a low forecast of $1.00. MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of 31.58% and 139.26%, respectively, for the quarter ended December 2021. MEI Pharma, Inc. was incorporated in 2000 and is headquartered in San Diego, California. The average twelve-month price prediction for MEI Pharma is $5.13 with a high price target of $20.00 and a low price target of $1.00. MEI Pharma, Inc. (MEIP) Analyst Ratings, Estimates & Forecasts - Yahoo! In-depth view of key statistics and finances for MEI PHARMA, INC. (MEIP) on MSN Money. MEIP | MEI Pharma Inc. Stock Overview (U.S.: Nasdaq) | Barron's MEI Pharma Price Target, Predictions & Analyst Ratings On average, they expect MEI Pharma's share price to reach $5.13 in the next year. After each calculation, the program assigns a buy, sell or hold value for each study . 2022-06-04 | NDAQ:MEIP | Press Release | MEI Pharma Inc. The 6 analysts offering price forecasts for MEI Pharma have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 1.00. The. The low in the last 52 weeks of MEI Pharma stock was 0.41. MEI Pharma (MEIP) stock price prediction is 0 USD. The MEI Pharma stock ... The average price target is $5.00 with a high forecast of $15.00 and a low forecast of $1.00. Find real-time MEIP - MEI Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. MEI Pharma Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Real time MEI Pharma (MEIP) stock price quote, stock graph, news & analysis. Future price of the stock is predicted at 0$ ( -100% ) after a year according to our prediction system. Quarterly Numbers. This means that if you invested $100 now, your current investment may be worth 0$ on 2023 June 05, Monday. View analysts' price targets for MEI Pharma or view top-rated stocks among Wall Street analysts. MEI PHARMA INC Stock Forecast, Predictions & Price Target A. MEI Pharma - MEIP - Stock Price Today - Zacks Q3 2021. 52-Week Range $0.41 - $3.55 Dividend & Yield N/A (N/A) MEIP Stock Predictions, Articles, and Mei Pharma Inc News From InvestorPlace From the Web 27 Biotechnology Stocks to Sell Now By Portfolio. (NASDAQ: MEIP) MEI PHARMA's current Earnings Per Share (EPS) is -$0.41. MEIP - Research and Analysis for MEI PHARMA, INC. - MSN About MEI Pharma. MEI Pharma expands early-stage zandelisib trial in specific blood cancer cohorts SA News Mon, Jan. 04, 2021 1 Comment MEI Pharma EPS misses by $0.06, beats on revenue . The average price target represents a 787.78% change from the last price of $0.56. Its drug candidates include Pracinostat, an oral HDAC inhibitor . Alliance Global Partners Thinks MEI Pharma's Stock is Going to Recover. MEIP -- Is Its Stock Price A Worthy Investment? Learn More. MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates (Expected Surprise Prediction) looks to find companies that have recently seen . MEI Pharma (MEIP) stock price prediction is 0 USD. The MEI Pharma stock ... . MEIP - MEI Pharma, Inc., Stock Quote, Analysis, Rating and News MEIP Issuance of Stock as of today (June 05, 2022) is $52.26 Mil. The highest, average, and lowest price target of all analysts. Interactive Chart MEIP S&P 500 Index Compare MEIP Stock to Peers News & Analysis: MEI Pharma. According to the issued ratings of 7 analysts in the last year, the consensus rating for MEI Pharma stock is Buy based on the current 3 hold ratings and 4 buy ratings for MEIP. MEIP Stock | News | MEI PHARMA Stock Price Today | Analyst Opinions ... See MEI Pharma, Inc. (MEIP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. More. What are analysts forecasts for MEI Pharma stock? Sat, 04 Jun 2022 MEI Pharma (MEIP) Stock Price: Why It Increased . MEI Pharma Stock Forecast & Price Targets - TipRanks MEI Pharma, Inc. (MEIP) delivered earnings and revenue surprises of -46.67% and 340.09%, respectively, for the quarter ended December 2020. MEI PHARMA ALERT: Bragar Eagel & Squire, P.C. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the expansion of its management team with the addition of two . Barchart Opinions show traders what a variety of popular trading systems are suggesting in terms of going long or short the market. What is MEIP's Earnings Per Share (EPS) forecast for 2022-2024? Actuals. The Opinions takes up to 5 years' worth of historical data and runs these prices through thirteen different technical indicators. The average MEI PHARMA stock price prediction forecasts a potential upside of 437.57% from the current MEIP share price of $0.53. MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates. MEI Pharma Stock Forecast & Price Targets - TipRanks On average, they expect MEI Pharma's share price to reach $5.13 in the next year. Q4 2021. Get the latest MEI Pharma, Inc MEIP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. MEI Pharma (NASDAQ:MEIP), Analyst Ratings, Price Targets, Predictions MEIP Stock Predictions, Articles, and Mei Pharma Inc News From InvestorPlace From the Web 27 Biotechnology Stocks to Sell Now By Portfolio Grader Nov 7, 2016 This week, 27 Biotechnology stocks are . Get the latest MEI Pharma, Inc MEIP detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. See MEI Pharma, Inc. (MEIP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. AC Immune's average media sentiment score of 0.84 beat MEI Pharma's score of -0.42 indicating that AC Immune is being referred to more favorably in the media. MEI Pharma (MEIP) Stock Price, News & Info | The Motley Fool Is the Options Market Predicting a Spike in MEI Pharma (MEIP) Stock? Based on 9 Wall Street analysts offering 12 month price targets for MEI Pharma in the last 3 months. Today's 52-Week Highs; Today's 52-Week Lows; Volume . MEI Pharma : Announces Pricing of Public Offering of Common Stock ... Learn more on MEIP's analyst rating . 6 Wall Street analysts have issued 12-month price targets for MEI Pharma's shares. MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced data from the ongoing Phase 2 TIDAL study evaluating the intermittent dosing of zandelisib, an . In-depth view of key statistics and finances for MEI PHARMA, INC. (MEIP) on MSN Money. Stock Picks. In depth view into MEI Pharma Issuance of Stock explanation, calculation, historical data and more . A high-level overview of MEI Pharma, Inc. (MEIP) stock. MEIP Stock Forecast, Price & News (MEI Pharma) - MarketBeat MEIP - Mei Pharma Stock Barchart Opinion - Barchart.com MEI Pharma, Inc. (MEIP) Latest Stock News | Seeking Alpha MEI Pharma Price Target, Predictions & Analyst Ratings According to the current price, MEI Pharma is 132.93% away from the 52-week low. MEIP - MEI Pharma Inc Stock quote - CNNMoney.com MEI PHARMA INC Stock Forecast, Predictions & Price Target MEI Pharma (MEIP) Stock Competitors and Alternatives 2022 MEI PHARMA, INC. : Revenue and Earnings Analysts Forecasts Revisions ... MEIP Issuance of Stock | MEI Pharma - GuruFocus.com MEIP updated stock price target summary. Why MEI Pharma Is Tanking 15.3% Today | The Motley Fool Do the numbers hold clues to what lies ahead for the stock? MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEI Pharma (MEIP) Stock Price, News & Info | The Motley Fool Shares in MEI Pharma ( MEIP -3.51%) are tumbling 15.3% at 11:55 a.m. EDT on Thursday following news its collaboration partner, Helsinn Group, is discontinuing a phase 3 trial of pracinostat in. The average MEI PHARMA stock price prediction forecasts a potential upside of 518.56% from the current MEIP share price of $0.46. MEIP : 0.5566 (-6.03%) MEI Pharma Strengthens Clinical and Quality Expertise with New Key Executive Appointments Business Wire - Mon Feb 7, 7:00AM CST. San Diego - December 1, 2021 - MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced today that it has priced the underwritten public offering of 17,500,000 shares of its common stock at $2.60 per share for total gross proceeds (before underwriting discount and commissions . MEI Pharma, Inc. (MEIP) Stock Price, Quote & News - Stock Analysis MEI Pharma Inc. MEI Pharma, Inc. is a pharmaceutical company, which engages in the clinical development of therapies for cancer. Mei Pharma Inc (MEIP) Latest News & Price | InvestorPlace MEI Pharma, Inc. (Nasdaq: MEIP) is a late-stage pharmaceutical company focused on developing potential new therapies for cancer. MEI Pharma's portfolio of drug candidates . The company's shares closed last Thursday at $1.83, close to its 52-week low of $1.68. MEI Pharma, Inc. (MEIP) Stock Price Today, Quote & News About the MEI Pharma Inc stock forecast. What is MEIP's Earnings Per Share (EPS) forecast for 2022-2024? Alliance Global Partners analyst Matthew Cross maintained a Buy rating on MEI Pharma (MEIP - Research Report) today and set a price target of $9.00. This suggests a possible upside of 710.9% from the stock's current price. On average, analysts forecast that MEIP's EPS will be -$0.59 for 2022, with the . MEIP | MEI Pharma Inc. Profile | MarketWatch Estimates. This suggests a possible upside of 710.9% from the stock's current price. Will MEI Pharma, Inc. (MEIP) Report Negative Q2 Earnings? What You ... As of 2022 June 05, Sunday current price of MEIP stock is 0.527$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. MEI Pharma stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period. While ratings are subjective and will change, the latest MEI Pharma ( MEIP) rating was a maintained with a price target of $11.00 to $4.00. This company is expected to post quarterly loss of $0.19 per share in its upcoming report, which represents a year-over-year change of +13.6%. MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Tops Revenue Estimates. MEI Pharma - MEIP - Stock Price Today - Zacks msn back to msn home money.